Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze ALGS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate ALGS investment potential.

What is ALGS stock price today?

Get real-time ALGS stock price, historical data, and price charts on Financhill. Track ALGS performance with our advanced analysis tools.

Is ALGS a good investment?

Evaluate ALGS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy ALGS stock?

To buy ALGS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of ALGS?

View detailed market capitalization data and company valuation metrics for ALGS on our comprehensive analysis page.

What is the P/E ratio of ALGS?

Use our fundamental analysis tools to view ALGS P/E ratio and compare valuation metrics with industry peers.

What are ALGS earnings?

View ALGS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Aligos Therapeutics, Inc. Stock Predictions

Get Your Free Stock Selector Checklist and Invest Smarter

Get Your Free Safe Stock Selector Checklist Now

Buy

ALGS
Aligos Therapeutics, Inc.

Last Price:

$10.70

Seasonality Move:

-0.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Safe Investing Checklist - Stay Clear of Risky Stocks

Get Your Free Safe Stock Selector Checklist Now

Aligos Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 5 years of stock performance.
Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
Is Aligos Therapeutics, Inc. Stock Undervalued?

The current Aligos Therapeutics, Inc. [ALGS] share price is $9.99. The Score for ALGS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will Aligos Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Aligos Therapeutics, Inc. has on average historically fallen by 32.1% based on the past 5 years of stock performance.

Aligos Therapeutics, Inc. Stock Rating

Buy

Aligos Therapeutics, Inc. (ALGS) is a Buy

Is Aligos Therapeutics, Inc. overpriced?

Aligos Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Aligos Therapeutics, Inc. Stock Price History

Is ALGS stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

aligos.com

52-Week Data

52-Week High:

46.80

52-Week Low:

3.76

Prediction Charts

Market Cap:

61.5M

Price in USD:

9.99

Volume:

33.8K

Beta:

2.75

Technical Analysis

SMA50:

9.01

SMA100:

9.16

SMA200:

8.60

52-Wk Change:

-64.28%

Stock Predictions

Is Aligos Therapeutics, Inc. stock public?

Yes, Aligos Therapeutics, Inc. is a publicly traded company.
What is the Aligos Therapeutics, Inc. stock quote today?

The Aligos Therapeutics, Inc. stock price is 9.99 USD today.
How to buy Aligos Therapeutics, Inc. stock online?

You can buy Aligos Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-17	6.65	7.02	7.31	6.64
Nov-18	6.95	7.92	8.19	6.94
Nov-19	8.00	8.23	8.59	8.00
Nov-20	8.43	8.26	8.63	8.07
Nov-21	8.37	9.21	9.22	8.09
Nov-24	9.21	9.52	9.58	8.69
Nov-25	9.52	9.66	9.98	9.39
Nov-26	9.47	9.86	9.98	9.47
Nov-28	9.95	9.58	9.95	9.50
Dec-1	9.37	9.30	9.92	9.18
Dec-2	9.35	9.21	9.48	9.10
Dec-3	9.20	9.87	10.00	9.14
Dec-4	9.89	10.09	10.45	9.80
Dec-5	10.12	9.99	10.26	9.84

Aligos Therapeutics, Inc. Earnings

Aligos Therapeutics, Inc. Earnings Report: Per Share Aligos Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aligos Therapeutics, Inc. Forecast Revenue Growth

Aligos Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Aligos Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.41 per share, and a decrease next year of $0.26 per share.

* Aligos Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.